SEC Form 4 · accession 0001261380-15-000021
IRIDEX CORP · IRIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William M Moore
Officer — Chairman and CEO · Director
Period of report
Feb 27, 2015
Accepted (ET)
Mar 16, 2015 · 7:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | M | 190,000 | — | A | 342,396 | D | |
| Common stock | Mar 13, 2015 | F | 61,465 | $9.08 | D | 280,931 | D | |
| Common Stock | holding | — | — | — | 78,944 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance RightsF2,F3 | — | Feb 27, 2015 | M | 190,000 | D | — | Feb 27, 2015 | Common Stock | 190,000 | 0 | D |
Explanation of responses
- F1Represents shares of Common stock issued upon the vesting of performance rights granted on March 25, 2013.
- F2The RSU's convert into the Issuer's Common Stock on a one-for-one basis.
- F3The performance right represents a contingent right to receive up to 220,000 shares of IRIDEX common stock. The number of shares issuable pursuant to the performance right was determined on February 27, 2015 based upon the Company's average stock price performance of fair market value, as set forth within a Restricted Stock Unit Award Agreement between IRIDEX and the reporting person.